Thursday, May 2, 2013

Decreasing Infections from a Prostate Biopsy

In today's video from Dr. Gerald Chodak, he discusses the risks of infection from having a prostate biopsy and what measures can be taken to minimize those risks. 


Monday, April 29, 2013

Supplements don't help with prostate cancer

NEW YORK (Reuters Health) - 

Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease.
Pulling together data from eight randomized controlled trials - considered the gold standard of medical research, researchers found non-herbal dietary supplements and vitamins didn't significantly change the severity of people's cancers.


"The main message would be that no miraculous supplement for (prostate cancer) exists," wrote Dr. Paul Posadzki, the review's lead author from the Korea Institute of Oriental Medicine in Daejeon, in an email to Reuters Health.

Sickle cell disease accounts for many priapism cases



NEW YORK (Reuters Health) - Thanks to commercials for erectile dysfunction drugs, men know to seek medical attention for "erections lasting more than four hours," but a new study suggests a blood disorder is the cause of many prolonged erections.
While the condition - formally known as priapism - is rare, researchers report in The Journal of Urology that between 14 percent and 30 percent of cases that show up in U.S. emergency rooms are men with sickle-cell disease.
"I would say what the paper is telling us is that sickle-cell disease is still responsible for the bulk of the visits for priapism," said Dr. Gregory Broderick, professor of urology at the Mayo Clinic in Jacksonville, Florida, who was not involved in the study.


Prostate cancer screening for older men 'unlikely'

 NHS Choices (Wed April 17, 2013)

There is wide coverage of new research that argues that routine screening could reduce deaths from prostate cancer, with BBC News, The Daily Telegraph and the Daily Mail all reporting the story. This controversial study is likely to reignite the debate about whether routine screening for prostate cancer does more harm than good.

Read the full NHS report

Wednesday, April 10, 2013

Doctors group questions prostate cancer screening

(Reuters Health)

The American College of Physicians (ACP) became the latest group to ask doctors to be clear about the limited benefits and "substantial harms" of prostate cancer screening before offering their male patients a prostate-specific antigen (PSA) test.


The ACP's guidance statement, published Monday in the Annals of Internal Medicine, also explicitly recommends against screening men younger than 50, older than 69 or with less than 10 to 15 years to live.

Men in their 50s and 60s may weigh the potential benefits and harms of PSA testing differently, which is why the idea of shared decision-making between patients and their doctors is so critical, said the ACP's Dr. Amir Qaseem.

Read the full Reuters Health report

Friday, April 5, 2013

Testosterone doesn't boost functioning in older men

(Reuters Health) - Older men who use testosterone gel may see small improvements in their muscle-to-fat ratio but are unlikely to glean any benefits in flexibility, endurance and general ability to get around, new research suggests.

Read More

Wednesday, April 3, 2013

Urine Biomarker Combo Predicts Prostate Cancer

Medscape News
MILAN, Italy

A combination of 2 urine-based genetic biomarkers predicts prostate cancer better than either biomarker alone and better than the standard serum prostate-specific antigen (PSA), according to a new study.

The 2 markers, PCA3 and the TMPRSS2:ERG gene fusion "can help stratify men for risk of cancer, significant cancer, and high-grade cancer at biopsy," said Jack Groskopf, PhD, director of oncology research and development at Hologic Gen-Probe in San Diego, California.

The company is currently developing both biomarkers. "We're hoping to show that the urine test results can help predict the probability of a positive biopsy and the probability that the biopsy will find clinically significant cancer that needs to be treated," Dr. Groskopf told Medscape Medical News.

Read More